Zavation Medical Products, backed by Gemspring Capital, has acquired Choice Spine, a Knoxville-based designer and manufacturer of spinal implant systems. The deal marks a significant expansion for Zavation, which is headquartered in Flowood, Mississippi, and specializes in spinal implants, interventional spine products, and biologics.

Concurrent with the acquisition, Zavation has appointed Derek Kuyper as CEO of the combined organization. Kuyper previously served as chief commercial officer of Zavation, bringing deep operational experience to the leadership role. Steve Ainsworth, co-president of ChoiceSpine, will remain with the company to support integration and ensure continuity during the transition.

Chirag Hirawat, principal at Gemspring Capital, stated that ChoiceSpine is a highly complementary addition that strengthens Zavation's competitive position in the spinal implant market. Founded in 2006, ChoiceSpine brings established product lines and market relationships to Zavation's portfolio. The acquisition positions the combined entity to execute on its long-term growth strategy in the spinal implant industry.